The development of pancreatic cancer is depending on numerous oncogenic modifications. Kras will be the most often mutated gene (G12D allele) in pancreatic cancer which is found in 95% of pancreatic cancers26. Whilst genetically engineered mouse (GEM) versions have convincingly shown that constitutive activation of Kras by itself is sufficient to t